Search Within

Larry Norton

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (95)
  2. Meeting Abstract (87)
  3. Editorial (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (184)
  2. Breast Medicine Service (184)
  3. Department of Medicine (184)
  4. Population Sciences Research Program (184)
  5. Solid Tumor Oncology Division (184)
  6. Survivorship Research (172)

More Groups

People
  1. Clifford Hudis (96)
  2. Mark Robson (89)
  3. Chau Dang (55)
  4. Katherine Panageas (47)
  5. Kenneth Offit (45)
  6. Maura Dickler (34)

More People

Years
  1. 2024 (8)
  2. 2023 (6)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (12)
  6. 2019 (13)

More Years

Publications
  1. Journal of Clinical Oncology (49)
  2. Breast Cancer Research and Treatment (22)
  3. Cancer Research (17)
  4. Clinical Cancer Research (12)
  5. Laboratory Investigation (7)
  6. American Journal of Human Genetics (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. American Association for Cancer Research (34)
  3. Springer (23)
  4. Nature Publishing Group (19)
  5. Oxford University Press (10)
  6. Cell Press (8)

More Publishers

Results (184)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Objective and subjective vulvovaginal symptoms in breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Saban, S.; Arkema, A.; Patil, S.; Flynn, J.; Goldfrank, D. J.; Norton, L.; Carter, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Evaluating the association between clonal hematopoiesis and germline pathogenic and likely pathogenic variants in cancer predisposition genes
    Meeting Abstract

    Comen, E. A.; Razavi, P.; Patel, P. B.; Martin, A.; Seshan, V. E.; Mandelker, D.; Ptashkin, R.; Kemel, Y.; Stadler, Z. K.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
    Journal Article

    Hoda, R. S.; Brogi, E.; Dos Anjos, C. H.; Grabenstetter, A.; Ventura, K.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Traina, T.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Patil, S.; Norton, L.; Robson, M.; Dang, C.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of breast cancer in African American women
    Meeting Abstract

    Serna-Tamayo, C.; Drago, J. Z.; Dos Anjos, C.; Herbert, J.; Pareja, F.; Modi, S.; Jhaveri, K.; Dang, C.; Solit, D. B.; Norton, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0
    Journal Article

    Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    Archives of Pathology & Laboratory Medicine (2020)

    Fulltext@MSK | Save